GSK plc - SPONSORED ADR (GSK)

Historical Portfolio Holders from Q1 2014 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / SPONSORED ADR
Shares, excl. options Q3 2024
1.09M
Holdings value Q3 2024
$44.4M
Value change Q3 2024
-$7.4M
Grand Portfolio weight change Q3 2024
0%
Number of holders
6
Number of buys Q3 2024
2
Number of sells Q3 2024
-2
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 1.09M $44.4M -$7.4M $40.87 6
2024 Q2 1.27M $48.9M -$473K $38.50 7
2024 Q1 1.28M $54.9M +$448K $42.87 9
2023 Q4 1.27M $47.1M -$923K $37.06 8
2023 Q3 1.3M $47M +$724K $36.25 9
2023 Q2 1.29M $45.5M -$504K $35.64 9
2023 Q1 1.29M $45.9M +$865K $35.58 9
2022 Q4 1.31M $46.4M -$40.6M $35.14 13
2022 Q3 2.67M $78.7M -$13.6B $29.43 31
2022 Q2 319M $13.9B -$351M $43.53 818
2022 Q1 331M $14.4B +$158M $43.56 909
2021 Q4 327M $14.4B +$216M $44.10 899
2021 Q3 323M $12.4B +$150M $38.21 773
2021 Q2 319M $12.7B -$343M $39.82 782
2021 Q1 316M $11.3B +$542M $35.69 759
2020 Q4 302M $11.1B +$196M $36.80 802
2020 Q3 298M $11.2B -$400M $37.64 815
2020 Q2 305M $12.4B -$290M $40.79 824
2020 Q1 312M $11.8B +$913M $37.89 804
2019 Q4 288M $13.5B +$322M $46.99 881
2019 Q3 282M $12B +$122M $42.68 801
2019 Q2 279M $11.2B -$33.6M $40.02 795
2019 Q1 280M $11.7B +$201M $41.79 839
2018 Q4 274M $10.5B +$77M $38.21 788
2018 Q3 273M $11B +$215M $40.17 785
2018 Q2 268M $10.8B -$297M $40.31 786
2018 Q1 275M $10.8B +$122M $39.07 775
2017 Q4 273M $9.67B +$1.02B $35.47 753
2017 Q3 242M $9.84B +$529M $40.60 732
2017 Q2 229M $9.88B +$361M $43.12 770
2017 Q1 221M $9.32B +$525M $42.16 775
2016 Q4 208M $8.03B +$50.4M $38.51 753
2016 Q3 207M $8.93B -$126M $43.13 726
2016 Q2 210M $9.1B +$227M $43.34 728
2016 Q1 205M $8.33B -$335M $40.55 710
2015 Q4 215M $8.69B -$122M $40.35 707
2015 Q3 218M $8.39B -$433M $38.45 692
2015 Q2 232M $9.68B -$830M $41.65 709
2015 Q1 250M $11.5B -$115M $46.15 726
2014 Q4 254M $10.8B -$559M $42.74 717
2014 Q3 265M $12.2B -$645M $45.97 692
2014 Q2 278M $14.9B +$859M $53.48 711
2014 Q1 262M $14B -$162M $53.43 703